AJR Podcasts

Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.20.24509

David Robinson, MD discusses an AJR pilot study exploring 18F-Fluciclovine PET/MRI for initial staging of prostate cancer and the effects of androgen deprivation therapy on 18F-Fluciclovine uptake.

Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.20.24264

Giuseppe V. Toia, MD reviews a timely meta-analysis which defines the normal reference ranges for MRI-derived left ventricular strain in healthy adults.

Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.20.24758

Kerem Ozturk, MD discusses why awareness of early chest CT findings is required for early detection and accurate diagnosis of immune checkpoint inhibitor therapy-related adverse events such as pneumonitis, new consolidation, worsening thoracic tumor burden, pleural/pericardial effusion, and pulmonary emboli in the emergency department.

Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.20.24536

Tyler Richards, MD discusses an AJR article that found no significant increase in the intrinsic T1 signal in the globus pallidus and dentate nucleus after more than 10 administrations of gadobutrol in pediatric patients compared to matched-age gadolinium naïve control and discussion of similar imaging based and autopsy studies.

Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.20.24801

In this podcast, Pei-Kang (Ken) Wei, MD and Diana Litmanovich, MD first summarized the study by Reeves et al. and then provided an in-depth discussion about the current status and future direction of utilizing chest radiograph as a guiding tool for clinical management. Key aspects of the discussion are the practicality and applicability of the scoring system developed by Reeves et al., chest radiograph as a more desirable modality for evaluating patients with COVID-19 compared to CT, and chest radiograph as an outcome predictor.

Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.20.24364

While the primary manifestations of COVID-19 are respiratory in nature—it has become clear as we take care of patients and learn more that COVID can have an effect on the nervous system. On this podcast, Edgar Perez, MD discusses MRI findings of COVID related-Disseminated Leukoencephalaopathy, which should remain an important differential consideration in COVID patients with neurologic manifestations.

Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.20.24374

Wire localization has long been the standard of care for localization of non-palpable breast lesions. Additional wireless localization options exist, including use of radioactive seeds, magnetic markers, radar/infrared reflectors, or most recently a radiofrequency identification tags, which address some of the disadvantages involved in wire localization. Matthew Petterson, MD discusses results an AJR study of one year of use at a single institution that suggests that RF tag localization is a feasible alternative to wire localization.

Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.20.24567

Patients with borderline resectable and locally advanced pancreatic cancer receiving neoadjuvant therapy can have results comparable to patients with resectable tumor at presentation, however some patients have early recurrence after neoadjuvant therapy and resection. Jordan Perchik, MD discusses a new AJR study in which a team of radiologists evaluate multiple imaging parameters and tumor metrics to assess for characteristics to predict pathologic response prior to resection.

Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.20.24636

Michael Nellamattathil, DO discusses whether or not enteric contrast is necessary in the setting of penetrating traumatic injury in light of a recent AJR article on the subject.

Full article: https://www.ajronline.org/doi/10.2214/AJR.20.24117

Percutaneous interventions are the mainstay for patients with non-operative HCC. This podcast by Ben Kipper, MD examines a paper comparing outcomes between thermal ablation and stereotactic body radiation therapy following transarterial chemoembolization and how those outcomes might affect clinical treatment plans going forward.